Pat Brady has held the role of Director of the I2 Fund at Genome British Columbia, a non-profit organization, since September 2015. The I2Fund is focused on funding companies commercializing life science technologies.
Prior to this position, Mr. Brady was Vice President, Investments at Growthworks Capital Ltd, a venture capital fund management firm. At Growthworks from 1998 to 2015, Mr. Brady lead equity investments in numerous companies. He served as a Board Director or observer for over 13 private and public life science firms during this period including OncoGenex Pharmaceuticals Inc., Celator Pharmaceuticals Inc., Tekmira Pharmaceuticals (now Arbutus BioPharma Corp.) and Xenon Pharmaceuticals, Inc.
Prior to Growthworks, Mr. Brady spent six years in financial and operating roles with Inex Pharmaceuticals Inc. and a cleantech company, DynaMotive Technologies Corporation. He was also a professional athlete.
Mr. Brady holds a MBA and an HBA from the Ivey Business School. He resides in Vancouver, BC.